Showing results (551-560 of 7,006) with videos related to

Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|September 7, 2016
Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based studyP Neumair, L Joos, R Warschkow, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2016
Microenvironmental changes in the progression from adenocarcinoma in situ to minimally invasive adenocarcinoma and invasive lepidic predominant adenocarcinoma of the lungMasahito Naito, Keiju Aokage, Kouichi Saruwatari, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2016
Increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR-mutated non-small cell lung cancer treated with erlotinibSteffen Filskov Sorensen, Christina Demuth, Britta Weber, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2016
Comparison of survival of chronic obstructive pulmonary disease patients with or without a localized non-small cell lung cancerStefan S Jeppesen, Niels-Chr G Hansen, Tine Schytte, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2016
Immunohistochemical pattern analysis of squamous cell carcinoma: Lung primary and metastatic tumors of head and neckJunji Ichinose, Aya Shinozaki-Ushiku, Kazuhiro Nagayama, et al.
Lung Cancer (Amsterdam, Netherlands)|March 13, 2010
The immunohistochemical overexpression of ribonucleotide reductase regulatory subunit M1 (RRM1) protein is a predictor of shorter survival to gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC)Jae Jin Lee, Chi Hoon Maeng, Seon Kyung Baek, et al.
Lung Cancer (Amsterdam, Netherlands)|March 13, 2010
Surgical treatment of bronchial carcinoid tumors: a single-center experienceTiago Noguchi Machuca, Paulo Francisco Guerreiro Cardoso, Spencer Marcantonio Camargo, et al.
Lung Cancer (Amsterdam, Netherlands)|March 13, 2010
Phase I study of autologous dendritic cell tumor vaccine in patients with non-small cell lung cancerSoo-Jung Um, Young Jin Choi, Ho-Jin Shin, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Identification of I1171N resistance mutation in ALK-positive non-small-cell lung cancer tumor sample and circulating tumor DNAAlison C Johnson, Pascal Dô, Nicolas Richard, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Serum mass profile signature as a biomarker of early lung cancerPiotr Widlak, Monika Pietrowska, Joanna Polanska, et al.
Pageof 701